161 related articles for article (PubMed ID: 37831583)
1. Validation of Dual-Action Chemo-Radio-Labeled Nanocarriers with High Efficacy against Triple-Negative Breast Cancer.
Ilyas S; E M Sahnoun S; Szymura A; Pes J; Habib S; Florea A; Schäfer L; Buhl EM; Morgenroth A; Habib P; Mottaghy FM; Mathur S
ACS Appl Mater Interfaces; 2023 Oct; 15(42):48963-48977. PubMed ID: 37831583
[TBL] [Abstract][Full Text] [Related]
2. Multimodal Mesoporous Silica Nanocarriers for Dual Stimuli-Responsive Drug Release and Excellent Photothermal Ablation of Cancer Cells.
Tran VA; Vo VG; Shim K; Lee SW; An SSA
Int J Nanomedicine; 2020; 15():7667-7685. PubMed ID: 33116494
[TBL] [Abstract][Full Text] [Related]
3. Improving anti-cancer drug delivery performance of magnetic mesoporous silica nanocarriers for more efficient colorectal cancer therapy.
Iranpour S; Bahrami AR; Nekooei S; Sh Saljooghi A; Matin MM
J Nanobiotechnology; 2021 Oct; 19(1):314. PubMed ID: 34641857
[TBL] [Abstract][Full Text] [Related]
4. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
[TBL] [Abstract][Full Text] [Related]
5. iRGD mediated pH-responsive mesoporous silica enhances drug accumulation in tumors.
Wang X; Zhao Y; Yan M; Liang X; Zhao N; Lu T
Eur J Pharm Sci; 2024 Apr; 195():106725. PubMed ID: 38346565
[TBL] [Abstract][Full Text] [Related]
6. Amine-functionalized, porous silica-coated NaYF
Reddy KL; Sharma PK; Singh A; Kumar A; Shankar KR; Singh Y; Garg N; Krishnan V
Mater Sci Eng C Mater Biol Appl; 2019 Mar; 96():86-95. PubMed ID: 30606601
[TBL] [Abstract][Full Text] [Related]
7. Polydopamine coated hollow mesoporous silica nanoparticles as pH-sensitive nanocarriers for overcoming multidrug resistance.
Shao M; Chang C; Liu Z; Chen K; Zhou Y; Zheng G; Huang Z; Xu H; Xu P; Lu B
Colloids Surf B Biointerfaces; 2019 Nov; 183():110427. PubMed ID: 31408782
[TBL] [Abstract][Full Text] [Related]
8. Enzyme-responsive cell-penetrating peptide conjugated mesoporous silica quantum dot nanocarriers for controlled release of nucleus-targeted drug molecules and real-time intracellular fluorescence imaging of tumor cells.
Li J; Liu F; Shao Q; Min Y; Costa M; Yeow EK; Xing B
Adv Healthc Mater; 2014 Aug; 3(8):1230-9. PubMed ID: 24550203
[TBL] [Abstract][Full Text] [Related]
9. Polymer-Coated Hollow Mesoporous Silica Nanoparticles for Triple-Responsive Drug Delivery.
Zhang Y; Ang CY; Li M; Tan SY; Qu Q; Luo Z; Zhao Y
ACS Appl Mater Interfaces; 2015 Aug; 7(32):18179-87. PubMed ID: 26221866
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Polydopamine-Coated Mesoporous Silica Nanorods and Spheres for the Delivery of Hydrophilic and Hydrophobic Anticancer Drugs.
Pada AK; Desai D; Sun K; Prakirth Govardhanam N; Törnquist K; Zhang J; Rosenholm JM
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336697
[TBL] [Abstract][Full Text] [Related]
11. Novel Multifunctional Stimuli-Responsive Nanoparticles for Synergetic Chemo-Photothermal Therapy of Tumors.
Pu XQ; Ju XJ; Zhang L; Cai QW; Liu YQ; Peng HY; Xie R; Wang W; Liu Z; Chu LY
ACS Appl Mater Interfaces; 2021 Jun; 13(24):28802-28817. PubMed ID: 34109788
[TBL] [Abstract][Full Text] [Related]
12. Mussel-inspired polydopamine coated mesoporous silica nanoparticles as pH-sensitive nanocarriers for controlled release.
Zheng Q; Lin T; Wu H; Guo L; Ye P; Hao Y; Guo Q; Jiang J; Fu F; Chen G
Int J Pharm; 2014 Mar; 463(1):22-6. PubMed ID: 24393764
[TBL] [Abstract][Full Text] [Related]
13. A novel microwave stimulus remote-controlled anticancer drug release system based on Janus TiO
Liu Y; Si Y; Di M; Tang D; Meng L; Cui B
Mater Sci Eng C Mater Biol Appl; 2021 Apr; 123():111968. PubMed ID: 33812596
[TBL] [Abstract][Full Text] [Related]
14. Carriers for hydrophobic drug molecules: lipid-coated hollow mesoporous silica particles, and the influence of shape and size on encapsulation efficiency.
Iqbal S; Schneider TK; Truong TT; Ulrich-Müller R; Nguyen PH; Ilyas S; Mathur S
Nanoscale; 2024 Jun; 16(23):11274-11289. PubMed ID: 38787696
[TBL] [Abstract][Full Text] [Related]
15. A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells.
Shen Y; Li M; Liu T; Liu J; Xie Y; Zhang J; Xu S; Liu H
Int J Nanomedicine; 2019; 14():4029-4044. PubMed ID: 31213813
[No Abstract] [Full Text] [Related]
16. Bovine serum albumin-based and dual-responsive targeted hollow mesoporous silica nanoparticles for breast cancer therapy.
Zhang Y; Ye Z; He R; Li Y; Xiong B; Yi M; Chen Y; Liu J; Lu B
Colloids Surf B Biointerfaces; 2023 Apr; 224():113201. PubMed ID: 36822117
[TBL] [Abstract][Full Text] [Related]
17. From The Mine to Cancer Therapy: Natural and Biodegradable Theranostic Silicon Nanocarriers from Diatoms for Sustained Delivery of Chemotherapeutics.
Maher S; Kumeria T; Wang Y; Kaur G; Fathalla D; Fetih G; Santos A; Habib F; Evdokiou A; Losic D
Adv Healthc Mater; 2016 Oct; 5(20):2667-2678. PubMed ID: 27594524
[TBL] [Abstract][Full Text] [Related]
18. Fabricating polydopamine-coated MoSe
Chai S; Kan S; Sun R; Zhou R; Sun Y; Chen W; Yu B
Int J Nanomedicine; 2018; 13():7607-7621. PubMed ID: 30510420
[TBL] [Abstract][Full Text] [Related]
19. Fabrication of biodegradable Mn-doped mesoporous silica nanoparticles for pH/redox dual response drug delivery.
Li X; Zhang X; Zhao Y; Sun L
J Inorg Biochem; 2020 Jan; 202():110887. PubMed ID: 31670257
[TBL] [Abstract][Full Text] [Related]
20. Preparation, Biosafety, and Cytotoxicity Studies of a Newly Tumor-Microenvironment-Responsive Biodegradable Mesoporous Silica Nanosystem Based on Multimodal and Synergistic Treatment.
He Z; Zhang H; Li H; Wang Y; Qian J; Cai X; Sun L; Huang J
Oxid Med Cell Longev; 2020; 2020():7152173. PubMed ID: 33488930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
